BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29156054)

  • 1. Hospice care, cancer-directed therapy, and Medicare expenditures among older patients dying with malignant brain tumors.
    Dover LL; Dulaney CR; Williams CP; Fiveash JB; Jackson BE; Warren PP; Kvale EA; Boggs DH; Rocque GB
    Neuro Oncol; 2018 Jun; 20(7):986-993. PubMed ID: 29156054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations Between End-of-Life Expenditures and Hospice Stay Length Vary by Clinical Condition and Expenditure Duration.
    Hung P; Hsu SH; Wang SY
    Value Health; 2020 Jun; 23(6):697-704. PubMed ID: 32540226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospice utilization among Medicare beneficiaries dying from pancreatic cancer.
    Paredes AZ; Hyer JM; Tsilimigras DI; Mehta R; Sahara K; White S; Dillhoff ME; Ejaz A; Cloyd JM; Pawlik TM
    J Surg Oncol; 2019 Sep; 120(4):624-631. PubMed ID: 31290170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between the Medicare hospice benefit and health care utilization and costs for patients with poor-prognosis cancer.
    Obermeyer Z; Makar M; Abujaber S; Dominici F; Block S; Cutler DM
    JAMA; 2014 Nov; 312(18):1888-96. PubMed ID: 25387186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicare program expenditures associated with hospice use.
    Campbell DE; Lynn J; Louis TA; Shugarman LR
    Ann Intern Med; 2004 Feb; 140(4):269-77. PubMed ID: 14970150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional variation in the association between advance directives and end-of-life Medicare expenditures.
    Nicholas LH; Langa KM; Iwashyna TJ; Weir DR
    JAMA; 2011 Oct; 306(13):1447-53. PubMed ID: 21972306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in Medicare Utilization and Expenditures in the Last Six Months of Life among Patients with and without Alzheimer's Disease and Related Disorders.
    Crouch E; Probst JC; Bennett K; Eberth JM
    J Palliat Med; 2019 Feb; 22(2):126-131. PubMed ID: 30328762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age and gender differences in Medicare expenditures at the end of life for colorectal cancer decedents.
    Shugarman LR; Bird CE; Schuster CR; Lynn J
    J Womens Health (Larchmt); 2007 Mar; 16(2):214-27. PubMed ID: 17388738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longer Periods Of Hospice Service Associated With Lower End-Of-Life Spending In Regions With High Expenditures.
    Wang S; Hsu SH; Huang S; Soulos PR; Gross CP
    Health Aff (Millwood); 2017 Feb; 36(2):328-336. PubMed ID: 28167723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospice care and resource utilization in Medicare beneficiaries with heart failure.
    Blecker S; Anderson GF; Herbert R; Wang NY; Brancati FL
    Med Care; 2011 Nov; 49(11):985-91. PubMed ID: 22002645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age and gender differences in medicare expenditures and service utilization at the end of life for lung cancer decedents.
    Shugarman LR; Bird CE; Schuster CR; Lynn J
    Womens Health Issues; 2008; 18(3):199-209. PubMed ID: 18457755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospice Use, Hospitalization, and Medicare Spending at the End of Life.
    Zuckerman RB; Stearns SC; Sheingold SH
    J Gerontol B Psychol Sci Soc Sci; 2016 May; 71(3):569-80. PubMed ID: 26655645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of age on Medicare expenditures and medical care in the last year of life.
    Levinsky NG; Yu W; Ash A; Moskowitz M; Gazelle G; Saynina O; Emanuel EJ
    JAMA; 2001 Sep; 286(11):1349-55. PubMed ID: 11560540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospice effect on government expenditures among nursing home residents.
    Gozalo PL; Miller SC; Intrator O; Barber JP; Mor V
    Health Serv Res; 2008 Feb; 43(1 Pt 1):134-53. PubMed ID: 18211522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What length of hospice use maximizes reduction in medical expenditures near death in the US Medicare program?
    Taylor DH; Ostermann J; Van Houtven CH; Tulsky JA; Steinhauser K
    Soc Sci Med; 2007 Oct; 65(7):1466-78. PubMed ID: 17600605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managed care, hospice use, site of death, and medical expenditures in the last year of life.
    Emanuel EJ; Ash A; Yu W; Gazelle G; Levinsky NG; Saynina O; McClellan M; Moskowitz M
    Arch Intern Med; 2002 Aug 12-26; 162(15):1722-8. PubMed ID: 12153375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospice Visit Patterns in the Last Seven Days of Life and the Service Intensity Add-On Payment.
    Gozalo PL; Teno JM; Spence C
    J Palliat Med; 2017 Dec; 20(12):1378-1384. PubMed ID: 28622481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospice use and public expenditures at the end of life in assisted living residents in a Florida Medicaid waiver program.
    Meng H; Dobbs D; Wang S; Hyer K
    J Am Geriatr Soc; 2013 Oct; 61(10):1777-81. PubMed ID: 24117288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Government expenditures at the end of life for short- and long-stay nursing home residents: differences by hospice enrollment status.
    Miller SC; Intrator O; Gozalo P; Roy J; Barber J; Mor V
    J Am Geriatr Soc; 2004 Aug; 52(8):1284-92. PubMed ID: 15271115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of hospice disenrollment on health care use and medicare expenditures for patients with cancer.
    Carlson MD; Herrin J; Du Q; Epstein AJ; Barry CL; Morrison RS; Back AL; Bradley EH
    J Clin Oncol; 2010 Oct; 28(28):4371-5. PubMed ID: 20805463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.